ATE419846T1 - Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese - Google Patents

Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese

Info

Publication number
ATE419846T1
ATE419846T1 AT04708802T AT04708802T ATE419846T1 AT E419846 T1 ATE419846 T1 AT E419846T1 AT 04708802 T AT04708802 T AT 04708802T AT 04708802 T AT04708802 T AT 04708802T AT E419846 T1 ATE419846 T1 AT E419846T1
Authority
AT
Austria
Prior art keywords
analogas
erythropoiesis
stimulators
glycerides
fatty acids
Prior art date
Application number
AT04708802T
Other languages
English (en)
Inventor
Christopher Penney
Lyne Gagnon
Pierre Laurin
Boulos Zacharie
Original Assignee
Prometic Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc
Application granted granted Critical
Publication of ATE419846T1 publication Critical patent/ATE419846T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04708802T 2003-02-07 2004-02-06 Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese ATE419846T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44545403P 2003-02-07 2003-02-07

Publications (1)

Publication Number Publication Date
ATE419846T1 true ATE419846T1 (de) 2009-01-15

Family

ID=32850990

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04708802T ATE419846T1 (de) 2003-02-07 2004-02-06 Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese

Country Status (28)

Country Link
US (1) US9682054B2 (de)
EP (1) EP1592416B1 (de)
JP (1) JP5390070B2 (de)
KR (1) KR101120775B1 (de)
CN (1) CN100427081C (de)
AP (1) AP2005003367A0 (de)
AR (1) AR043120A1 (de)
AT (1) ATE419846T1 (de)
AU (1) AU2004210193B2 (de)
BR (1) BRPI0407276A (de)
CA (1) CA2515160C (de)
CY (1) CY1108963T1 (de)
DE (2) DE04708802T1 (de)
DK (1) DK1592416T3 (de)
EA (1) EA009939B1 (de)
ES (1) ES2255467T3 (de)
IL (1) IL170057A (de)
JO (1) JO2705B1 (de)
MA (1) MA27664A1 (de)
MX (1) MXPA05008382A (de)
MY (1) MY140913A (de)
NO (1) NO334085B1 (de)
NZ (1) NZ541593A (de)
PT (1) PT1592416E (de)
SI (1) SI1592416T1 (de)
TN (1) TNSN05189A1 (de)
WO (1) WO2004069237A1 (de)
ZA (1) ZA200506246B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1385498E (pt) 2001-04-18 2007-12-14 Prometic Biosciences Inc Ácidos gordos como factores de sobrevivência e activação de neutrófilos
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
AU2005329255B2 (en) * 2004-04-15 2010-09-30 Chiasma, Inc. Compositions capable of facilitating penetration across a biological barrier
EP3489257A1 (de) 2004-07-23 2019-05-29 Acceleron Pharma Inc. Actrii-rezeptor-polypeptide, verfahren und zusammensetzungen
EA200700543A1 (ru) * 2004-09-03 2007-10-26 Прометик Байосайенсиз Инк. Замещенные пуринилпроизводные с иммуномодулирующей и химиозащитной активностью и их применение как таковых или с жирными кислотами со средней длиной цепи или глицеридами
EP1804780B1 (de) 2004-10-01 2011-11-16 ProMetic BioSciences Inc. Mittelkettige fettalkohole als blutbildungsstimulatoren
US8071580B2 (en) 2004-10-01 2011-12-06 Prometic Biosciences Inc. Medium-chain length fatty alcohols as stimulators of hematopoiesis
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
PT1973559E (pt) 2005-11-23 2013-02-19 Acceleron Pharma Inc Antagonistas de activina-actriia e utilizações para promover o crescimento ósseo
US8895016B2 (en) 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
TWI584815B (zh) 2007-02-01 2017-06-01 艾瑟勒朗法瑪公司 活化素-ＡｃｔＲＩＩａ拮抗劑及其治療或預防乳癌之用途
TWI548647B (zh) 2007-02-02 2016-09-11 艾瑟勒朗法瑪公司 衍生自ＡｃｔＲＩＩＢ的變體與其用途
TWI606062B (zh) 2007-02-09 2017-11-21 艾瑟勒朗法瑪公司 包含ＡｃｔＲＩＩａ-Ｆｃ融合蛋白的醫藥組合物；ＡｃｔＲＩＩａ-Ｆｃ融合蛋白於治療或預防與癌症相關的骨質流失之用途；ＡｃｔＲＩＩａ-Ｆｃ融合蛋白於治療或預防多發性骨髓瘤之用途
CN107412734A (zh) 2007-09-18 2017-12-01 阿塞勒隆制药公司 活化素‑actriia拮抗剂和减少或抑制fsh分泌的用途
MY151439A (en) 2007-11-02 2014-05-30 Prometic Biosciences Inc Medium-chain length fatty acids and glycerides as nephroprotection agents
WO2009076761A1 (en) * 2007-12-19 2009-06-25 Prometic Biosciences Inc. Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
TWI626945B (zh) 2008-08-14 2018-06-21 艾瑟勒朗法瑪公司 使用ｇｄｆ阱以增加紅血球水平
CN106974888B (zh) * 2008-09-17 2019-08-02 克艾思马有限公司 药物组合物和相关的给药方法
MX355042B (es) 2009-06-08 2018-04-02 Acceleon Pharma Inc Metodos para aumentar adipositos termogenicos.
CN102656187A (zh) 2009-06-12 2012-09-05 阿塞勒隆制药公司 截短的actriib-fc融合蛋白
BR112012003232B1 (pt) * 2009-08-13 2022-02-22 Acceleron Pharma Inc Uso de um polipeptídeo em conjunto com um ativador do receptor de eritropoetina para aumentar os níveis de célula vermelha no sangue ou tratar anemia
US8710016B2 (en) 2009-11-17 2014-04-29 Acceleron Pharma, Inc. ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
KR20130132824A (ko) 2010-11-08 2013-12-05 악셀레론 파마 인코포레이티드 Actriia 결합제 및 이의 용도
TWI572352B (zh) * 2012-03-01 2017-03-01 波麥堤克藥學Ｓｍｔ有限公司 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法
EP2914277B1 (de) 2012-11-02 2017-09-13 Celgene Corporation Activin-actrii-antagonisten und verwendungen zur behandlung von knochen- und anderen erkrankungen
CN102973922B (zh) * 2012-12-18 2016-02-03 华东理工大学 一种融合蛋白的应用
CN114699529A (zh) 2014-06-13 2022-07-05 阿塞勒隆制药公司 用于治疗溃疡的方法和组合物
MA41052A (fr) 2014-10-09 2017-08-15 Celgene Corp Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
TWI730949B (zh) 2014-12-03 2021-06-21 美商西建公司 活化素-ａｃｔｒｉｉ拮抗劑及治療貧血之用途
CA2975599A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
US20170021029A1 (en) * 2015-04-15 2017-01-26 Jeffrey Charles Raber Topical formulations and uses
MX2021003750A (es) 2018-10-11 2021-06-15 Basf As Compuestos aromaticos y usos farmaceuticos de los mismos.
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871768A (en) 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
US6054441A (en) 1987-10-28 2000-04-25 Pro-Neuron, Inc. Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
US5011852A (en) 1988-07-25 1991-04-30 Applied Analytical Industries, Inc. Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
JP3014119B2 (ja) * 1990-05-28 2000-02-28 雪印乳業株式会社 直腸投与用赤血球造血剤
JP3249147B2 (ja) 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
EP0495187B1 (de) * 1991-01-15 1997-01-22 Hemosphere, Inc. Protein Nanomatrizen und Verfahren zur Herstellung
JPH05163160A (ja) 1991-12-13 1993-06-29 Snow Brand Milk Prod Co Ltd 免疫低下に伴う感染症の予防及び治療用栄養剤
US5214035A (en) 1992-04-16 1993-05-25 Hoechst-Roussel Agri-Vet Company Thixotropic formulations
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
WO1995030413A1 (en) * 1994-05-10 1995-11-16 The Kitasato Institute Hematopoietic stem cell proliferation accelerator
US5470861A (en) 1994-08-04 1995-11-28 Hoffmann-La Roche Inc. Method of promoting hair growth
US5549905A (en) 1994-10-18 1996-08-27 Clintec Nutrition Co. Enternal composition for pediatric patients
IT1275802B1 (it) 1994-11-03 1997-10-17 Hoffmann La Roche Composizione di interferone
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
AUPN933396A0 (en) 1996-04-17 1996-05-09 Pfizer Pty Limited Non-aqueuos oral-drench compositions containing avermectin compounds
US5851534A (en) 1996-05-03 1998-12-22 Dynagen, Inc. Methods for prevention and/or treatment of neutropenia
JPH10265380A (ja) 1997-03-17 1998-10-06 Bristol Myers Squibb Co 抗ガン剤
EP1009383A1 (de) * 1997-09-04 2000-06-21 Biozone Laboratories, Inc. Orale liposomale verabreichungssysteme
IL135989A0 (en) * 1997-11-14 2001-05-20 Skyepharma Inc Processes for the production of multivesicular liposomes
ES2238775T3 (es) 1997-11-19 2005-09-01 Hercules Incorporated Suspensiones polimericas fluidificadas de polisacaridos cationicos en emolientes y su uso en la preparacion de composiciones para el cuidado personal.
DE69833333T2 (de) * 1997-11-20 2006-10-19 Jhon, Gil Ja Pharmazeutische zusammensetzung enthaltend geweihextrakte von cervus nippon mit wachstumsstimulierender aktivität auf hematopoietische stammzellen und megakaryozyten
ATE271376T1 (de) * 1998-02-23 2004-08-15 Cilag Ag Int Liposomale erythropoietin-dispersion
ATE246506T1 (de) 1998-03-11 2003-08-15 Grelan Pharmaceutical Co Darmlösliche sprudelnde zusammensetzungen
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
EP1216026A1 (de) 1999-09-27 2002-06-26 Sonus Pharmaceuticals, Inc. Zusammensetzungen mit tocol- löslichen wirkstoffen
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
WO2001095914A1 (en) 2000-06-14 2001-12-20 William Leslie Porter Lipids for modulating immune response
US6967028B2 (en) 2000-07-31 2005-11-22 Mainelab Prolonged release microspheres for injectable administration
IL142535A0 (en) 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
PT1385498E (pt) 2001-04-18 2007-12-14 Prometic Biosciences Inc Ácidos gordos como factores de sobrevivência e activação de neutrófilos
US20040052836A1 (en) 2002-09-13 2004-03-18 Li Luk Chiu Pharmaceutical compositions containing at least one stable liposphere having an improved shelf life
US6725510B1 (en) 2003-04-25 2004-04-27 Almetta Clyburn Inclining coffin
SI1648851T1 (sl) 2003-07-25 2007-10-31 Prometic Biosciences Inc Priprava kovinskih soli maščobnih kislin s srednjo verigo
EA200700543A1 (ru) 2004-09-03 2007-10-26 Прометик Байосайенсиз Инк. Замещенные пуринилпроизводные с иммуномодулирующей и химиозащитной активностью и их применение как таковых или с жирными кислотами со средней длиной цепи или глицеридами
US8071580B2 (en) 2004-10-01 2011-12-06 Prometic Biosciences Inc. Medium-chain length fatty alcohols as stimulators of hematopoiesis

Also Published As

Publication number Publication date
ES2255467T3 (es) 2009-05-01
JP5390070B2 (ja) 2014-01-15
IL170057A (en) 2011-09-27
AU2004210193B2 (en) 2007-07-12
DE04708802T1 (de) 2006-06-22
MY140913A (en) 2010-01-29
EP1592416A1 (de) 2005-11-09
TNSN05189A1 (en) 2007-06-11
EP1592416B1 (de) 2009-01-07
DE602004018902D1 (de) 2009-02-26
CA2515160A1 (en) 2004-08-19
CN100427081C (zh) 2008-10-22
MA27664A1 (fr) 2005-12-01
NZ541593A (en) 2009-05-31
US9682054B2 (en) 2017-06-20
AP2005003367A0 (en) 2005-09-30
AR043120A1 (es) 2005-07-20
CA2515160C (en) 2013-01-08
SI1592416T1 (sl) 2009-06-30
AU2004210193A1 (en) 2004-08-19
EA200501267A1 (ru) 2006-02-24
KR101120775B1 (ko) 2012-04-18
DK1592416T3 (da) 2009-04-20
JP2006516987A (ja) 2006-07-13
CY1108963T1 (el) 2014-07-02
WO2004069237A1 (en) 2004-08-19
ES2255467T1 (es) 2006-07-01
NO334085B1 (no) 2013-12-09
EA009939B1 (ru) 2008-04-28
MXPA05008382A (es) 2005-11-04
NO20053994D0 (no) 2005-08-26
NO20053994L (no) 2005-10-06
PT1592416E (pt) 2009-04-03
ZA200506246B (en) 2006-12-27
US20060128800A1 (en) 2006-06-15
CN1753665A (zh) 2006-03-29
KR20050118671A (ko) 2005-12-19
JO2705B1 (ar) 2014-03-15
BRPI0407276A (pt) 2006-01-31

Similar Documents

Publication Publication Date Title
ATE419846T1 (de) Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese
IL183246A0 (en) Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
DE60225081D1 (de) Herstellungsverfahren von Esterwachs
IL180602A0 (en) Composition containing statins and omega-3 fatty acids
DK1755565T3 (da) Blød gelatinekapsel omfattende polyumættede omega-3-fedtsyrer
DE50106453D1 (de) Verwendung von zuckertensiden und fettsäurepartialglyceriden
NO20034490D0 (no) Fremgangsmåte for sammensetting av absorberende gjenstand til personlig stell
NO20023879D0 (no) Partielle fettsyre-oksydasjonsinhibitorer i behandlingen av kongestiv hjertesvikt
MX2010003568A (es) Composiciones y metodos para mejorar la funcion cognitiva.
ZA200702280B (en) Fatty acid esters of alkanolamines and their use as softening agents
AU2003281542A8 (en) Preparation of microbial oil containing polyunsaturated fatty acids
EP1625208A4 (de) Neues lipolytisches enzym lip2
EP1448557A4 (de) Heteroindane: eine neue klasse hochwirksamer cannabimimetischer liganden
EP1685218A4 (de) Fettsäureester und deren verwendung
NO20055726D0 (no) Fiskeoljer med endret fettsyreprofil, fremgangsmate for fremstilling av samme og deres anvendelse
EP1565262A4 (de) VERFAHREN ZUR HERSTELLUNG EINER GETRûGERTEN AKTIVIERTEN KATALYSATOR ENTHALTENDEN ZUSAMMENSETZUNG
MA28366A1 (fr) Derives de piperidinylalkylcarbamates, leur preparation et leur application comme inhibiteurs de l'enzyme faah
HRP20151447T1 (hr) Kruti pripravak koji sadrži pioglitazon, glimepirid i ester masne kiseline polioksietilen-sorbitana
DE60223225D1 (de) Zündkerze und Herstellungsverfahren der Zündkerze
DE602004022034D1 (de) Herstellung von konjugierten linolsäuren und linolsäuresalzen
DE602005015486D1 (de) Esterderivate von ascorbinsäure und 2-ketosäuresacchariden
DE60020335D1 (de) Faserige matrix zum absorbieren von fett und öl
DE60224915D1 (de) Zündkerze und Herstellungsverfahren der Zündkerze
EP1123694A3 (de) Mund- und Zahnpflegemittel
ATE217389T1 (de) Verbrennung von fetten und ölen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1592416

Country of ref document: EP